0001171843-20-006336.txt : 20200908
0001171843-20-006336.hdr.sgml : 20200908
20200908181220
ACCESSION NUMBER: 0001171843-20-006336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200903
FILED AS OF DATE: 20200908
DATE AS OF CHANGE: 20200908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENNEMAN JOHN B III
CENTRAL INDEX KEY: 0001187572
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 201165054
MAIL ADDRESS:
STREET 1: 311 C ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0306
4
2020-09-03
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001187572
HENNEMAN JOHN B III
32 WIGGINS AVENUE
BEDFORD
MA
01730
1
0
0
0
Common Stock
2020-09-03
4
A
0
9310
0
A
9310
D
These shares represent restricted stock units. Each restricted stock unit represents the contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in three equal annual installments immediately prior to the Anika Therapeutics, Inc., Annual Meetings of Stockholders beginning in 2021, 2022, and 2023.
/s/ John B. Henneman, III
2020-09-08